176 related articles for article (PubMed ID: 25630554)
21. Cytochrome P450 1A1 (CYP1A1) polymorphisms and breast cancer risk in Korean women.
Shin A; Kang D; Choi JY; Lee KM; Park SK; Noh DY; Ahn SH; Yoo KY
Exp Mol Med; 2007 Jun; 39(3):361-6. PubMed ID: 17603290
[TBL] [Abstract][Full Text] [Related]
22. Quantitative synthesis of the association between the cytochrome P450 1A1 Ile462Val polymorphism and prostate cancer risk.
Han G; Ma Y; Liu P; Wei X; Zhang X; Zhu F
Tumour Biol; 2013 Jun; 34(3):1511-6. PubMed ID: 23381648
[TBL] [Abstract][Full Text] [Related]
23. CYP1A1 gene polymorphisms: lack of association with breast cancer susceptibility in the southern region (Madurai) of India.
Kiruthiga PV; Kannan MR; Saraswathi C; Pandian SK; Devi KP
Asian Pac J Cancer Prev; 2011; 12(8):2133-8. PubMed ID: 22292665
[TBL] [Abstract][Full Text] [Related]
24. Cytochrome P450 1A1 Ile462Val polymorphism and oral carcinoma risk: an updated meta-analysis including 1,515 cases and 2,233 controls.
Zhuo X; Zhao H; Chang A; Ye H; Zhou Y; Song Y; Tan Y
Tumour Biol; 2012 Dec; 33(6):2079-89. PubMed ID: 22847262
[TBL] [Abstract][Full Text] [Related]
25. Lack of association between the CYP1A1 Ile462Val polymorphism and endometrial cancer risk: a meta-analysis.
Wang XW; Zhong TY; Xiong YH; Lin HB; Liu QY
Asian Pac J Cancer Prev; 2012; 13(8):3717-21. PubMed ID: 23098461
[TBL] [Abstract][Full Text] [Related]
26. Functional CYP1A1 genetic variants, alone and in combination with smoking, contribute to development of head and neck cancers.
Liu L; Wu G; Xue F; Li Y; Shi J; Han J; Zhang X; Na Y; Zhang H; Tang X; Pu H; Yuan Q; Zhang L; Yang M
Eur J Cancer; 2013 Jun; 49(9):2143-51. PubMed ID: 23462525
[TBL] [Abstract][Full Text] [Related]
27. Cytochrome P450 1A1, cigarette smoking, and risk of endometrial cancer (United States).
McGrath M; Hankinson SE; De Vivo I
Cancer Causes Control; 2007 Dec; 18(10):1123-30. PubMed ID: 17717632
[TBL] [Abstract][Full Text] [Related]
28. CYP1A1 gene polymorphisms and polycystic ovary syndrome risk: a meta-analysis and meta-regression.
Shen W; Li T; Hu Y; Liu H; Song M
Genet Test Mol Biomarkers; 2013 Oct; 17(10):727-35. PubMed ID: 23848208
[TBL] [Abstract][Full Text] [Related]
29. CYP1A1 Ile462Val polymorphism contributes to lung cancer susceptibility among lung squamous carcinoma and smokers: a meta-analysis.
Ji YN; Wang Q; Suo LJ
PLoS One; 2012; 7(8):e43397. PubMed ID: 22952673
[TBL] [Abstract][Full Text] [Related]
30. Effects of cytochrome P450 1A1 and uridine-diphosphate-glucuronosyltransferase 1A1 allelic polymorphisms on the risk of development and the prognosis of head and neck cancers.
Szanyi I; Ráth G; Móricz P; Somogyvári K; Révész P; Gerlinger I; Orsós Z; Ember I; Kiss I
Eur J Cancer Prev; 2012 Nov; 21(6):560-8. PubMed ID: 22273851
[TBL] [Abstract][Full Text] [Related]
31. Association between CYP1A1 Ile462Val variation and acute leukemia risk: meta-analyses including 2164 cases and 4160 controls.
Zhuo W; Zhang L; Zhu B; Qiu Z; Chen Z
PLoS One; 2012; 7(10):e46974. PubMed ID: 23056546
[TBL] [Abstract][Full Text] [Related]
32. Cytochrome P450 1A1 (CYP1A1) polymorphism and susceptibility to esophageal cancer: an updated meta-analysis of 27 studies.
Gong FF; Lu SS; Hu CY; Qian ZZ; Feng F; Wu YL; Yang HY; Sun YH
Tumour Biol; 2014 Oct; 35(10):10351-61. PubMed ID: 25048966
[TBL] [Abstract][Full Text] [Related]
33. Association between cytochrome P450 1A1 MspI polymorphism and endometrial cancer risk: a meta-analysis.
Han L; Liu Y; Cao W; Yuan X; Li C
Tumour Biol; 2013 Oct; 34(5):2545-50. PubMed ID: 23918309
[TBL] [Abstract][Full Text] [Related]
34. The effect of CYP1A1 polymorphisms on the risk of lung cancer: a global meta-analysis based on 71 case-control studies.
Chen Z; Li Z; Niu X; Ye X; Yu Y; Lu S; Chen Z
Mutagenesis; 2011 May; 26(3):437-46. PubMed ID: 21402622
[TBL] [Abstract][Full Text] [Related]
35. CYP1A1 MspI polymorphisms and lung cancer risk: an updated meta-analysis involving 20,209 subjects.
Ji YN; Wang Q; Lin XQ; Suo LJ
Cytokine; 2012 Aug; 59(2):324-34. PubMed ID: 22579698
[TBL] [Abstract][Full Text] [Related]
36. Genetic Polymorphisms of Cytochrome P4501A1 (CYP1A1) and Glutathione S-Transferase P1 (GSTP1) and Risk of Hepatocellular Carcinoma Among Chronic Hepatitis C Patients in Egypt.
Abo-Hashem EM; El-Emshaty WM; Farag Rel S; Zakaria S; Abd El-Aziz M; Ghonaim A
Biochem Genet; 2016 Oct; 54(5):696-713. PubMed ID: 27271262
[TBL] [Abstract][Full Text] [Related]
37. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.
Singh V; Rastogi N; Sinha A; Kumar A; Mathur N; Singh MP
Breast Cancer Res Treat; 2007 Jan; 101(1):73-81. PubMed ID: 16807674
[TBL] [Abstract][Full Text] [Related]
38. Cytochrome P450 1A1 (CYP1A1) gene polymorphisms and ovarian cancer risk: a meta-analysis.
Sergentanis TN; Economopoulos KP; Choussein S; Vlahos NF
Mol Biol Rep; 2012 Nov; 39(11):9921-30. PubMed ID: 22733497
[TBL] [Abstract][Full Text] [Related]
39. CYP1A1 Ile462Val polymorphism contributes to colorectal cancer risk: a meta-analysis.
Jin JQ; Hu YY; Niu YM; Yang GL; Wu YY; Leng WD; Xia LY
World J Gastroenterol; 2011 Jan; 17(2):260-6. PubMed ID: 21246002
[TBL] [Abstract][Full Text] [Related]
40. CYP1A1 Ile462Val polymorphism and cervical cancer: evidence from a meta-analysis.
Yang S; Jia C; Zhu H; Han S
Tumour Biol; 2012 Dec; 33(6):2265-72. PubMed ID: 22948778
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
